MiniMed Group, Inc. Common Stock
MMED
Rang in Aktien
#3402
MiniMed Group, Inc. specializes in designing, producing, and distributing a... MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Aktienkurs
$17.87
Zuletzt synchronisiert: 2026-10-21
Marktkapitalisierung
$5.03B
Veränderung (1 Tag)
2.14%
Veränderung (1 Jahr)
-
Land
US
Handel MiniMed Group, Inc. Common Stock (MMED)
Kategorie
Healthcare
EPS für MiniMed Group, Inc. Common Stock (MMED)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von MiniMed Group, Inc. Common Stock beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von MiniMed Group, Inc. Common Stock von 2023 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2025 | $-0.89 | 122.50% |
| 2024 | $-0.40 | 17.65% |
| 2023 | $-0.34 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| $-0.61 | - |
US
|
|
| - | - |
US
|
|
| - | - |
US
|
|
| $-1.04 | - |
IL
|
|
| $0.86 | - |
US
|
